Endocrinology

Sitagliptin Tied to Improved Outcomes among Diabetics with COVID-19

October 01, 2020

Results of a study of more than 330 patients suggest use of sitagliptin could improve outcomes in patients with diabetes and COVID-19.

Generic Levothyroxine as Effective as Brand Name for Achieving Thyrotropin Goals

October 01, 2020

Study suggests generic levothyroxine achieved similar rates of patients with thyrotropin levels in the ideal range as brand name levothyroxine.

Exposure to Diabetes in the Womb Could Increase Heart Disease Risk

September 30, 2020

An analysis of nearly 300k offspring suggests those exposed to diabetes in the womb were at an increased risk of cardiovascular disease events and risk factors in young adulthood.

UVA Study Suggests NRTIs Could Reduce Risk of Developing Type 2 Diabetes

September 29, 2020

An analysis of data from 5 major databases suggests NRTIs could reduce incidence of type 2 diabetes.

Study Finds Increased Exercise Lowers Mortality Risk 25-32% Among Diabetics

September 25, 2020

A study presented at EASD 2020 examines the impact of increased exercise capacity on risk of all-cause mortality among more than 4k patients with type 2 diabetes.

Metformin Could Slow Cognitive Decline, Reduce Dementia Incidence in Diabetics

September 24, 2020

Analysis of information from more than 1000 patients in Australia sheds light on the potential association between metformin use and slower cognitive decline in older individuals.

COVID-19 Lockdown May Have Improved Glycemic Control for Some Diabetics

September 23, 2020

Data from a group of type 1 diabetics from a diabetes center in Italy suggests time off work and in lockdown could have been helped some patients improve glycemic control.

Study Estimates Average Life Years Lost from Type 1, Type 2 Diabetes

September 23, 2020

Research presented at EASD 2020 provides an updated estimate of the life years lost as a result of type 1 and type 2 diabetes, respectively, among patients in the UK.

Diabetics, Both Type 1 and Type 2, at Increased Risk of Falls, Fall-Related Injuries

September 22, 2020

A study from EASD 2020 found type 1 diabetes was associated with a 33% increase in risk of falls while type 2 diabetes was associated with a 19% increase in risk.

Rheumatoid Arthritis Tied to 23% Increase in Risk of New Diabetes

September 22, 2020

A study from EASD 2020 suggests patients with RA could be at a nearly 25% increase in risk of developing type 2 diabetes later in life.

Synthetic Medication, Desiccated Thyroid Similar in Effectiveness for Hypothyroidism

September 21, 2020

Results of the study offer clinicians greater insight and could improve decision-making in regards to treatment choices for hypothyroidism.

Study Finds Thyroid Inflammation Tied to Anxiety Disorders

September 19, 2020

A study from e-ECE 2020 suggests thyroid inflammation could put patients at greater risk for developing an anxiety disorder.

Feelings of Loneliness in Older Adults Tied to Increase Risk of New-Onset Diabetes

September 16, 2020

Analysis of data from a European aging study suggests feeling lonely was linked to an increased risk of developing diabetes in older adults.

Maternal PCOS Linked to Increased Risk of Neuropsychiatric Disorders in Offspring

September 10, 2020

New research suggests children born to mothers with PCOS could be at an increased risk of developing a psychiatric disorder later in life.

Cardiometabolic Health Fellowships: The Answer or Part of the Problem?

September 06, 2020

Melissa Young, MD, offers perspective on the push to create cardiometabolic fellowships versus making endocrinology a more desirable field.

Galectin-3 Plasma Levels Help Predict Cardiovascular Events in Diabetics

September 03, 2020

An ESC Congress 2020 study details the predictive value of galectin-3 levels for predicting risk of cardiovascular events in patients with type 2 diabetes

Prof. Heerspink: DAPA-CKD and Use of Dapagliflozin

September 03, 2020

A podcast featuring the presenter of DAPA-CKD discussing results of the trial and how they inform use of dapagliflozin in patients with chronic kidney disease with and without type 2 diabetes.

Diana Isaacs, PharmD: An Overview of Insulin Affordability in 2020

September 01, 2020

A look at the state of insulin affordability in 2020 and how the ongoing pandemic has impacted the situation.

HbA1c Levels Could Help Predict Heart Attack Risk Regardless of Sex

August 31, 2020

Analysis of the UK Biobank cohort details associations between increased HbA1c levels and risk of myocardial infarction in patients regardless of sex.

Exposure to Endocrine-Disrupting Chemicals Linked to ADHD in Adolescents

August 29, 2020

An analysis of data from the New Bedford Cohort suggests exposure to endocrine-disrupting chemicals could increased risk of ADHD in adolescents.